Acute myocarditis with autoimmune features: one-year follow-up with CMR
- PMID: 34373946
- DOI: 10.1007/s00380-021-01917-9
Acute myocarditis with autoimmune features: one-year follow-up with CMR
Abstract
In this prospective study on patients with acute myocarditis (AM), we aimed to describe the new concept of AMAF (AM with autoimmune features) similar to the previously described interstitial pneumonia with autoimmune features (IPAF). IPAF has recently emerged as a new entity, and IPAF patients appear to have fewer episodes of exacerbation and better survival than patients with idiopathic pulmonary fibrosis. Consecutive patients with infarct-like CMR-confirmed AM were classified AMAF if their serologic status measured from blood sampled at presentation was positive (antinuclear antibodies (ANA) ≥ 1:320), but without meeting established classification criteria for connective tissue disease (CTD). The myocardial tissue abnormalities and their progression were assessed on cardiac magnetic resonance (CMR) within 7 days following symptom onset and at 1 year according to their seropositivity. Among the 64 AM patients included, seven presented AMAF (11%). At baseline CMR, patients with AMAF had half as much late gadolinium enhancement (LGE) as seronegative AM patients (4.41% (1.47-4.41) of myocardial volume versus 8.82% (5.88-14.71), p = 0.01, respectively). At 1-year of follow-up, persistent myocardial scarring was less frequent in AMAF patients (n = 2 (28.6%) than seronegative AM patients (n = 38 (66.7%) (p = 0.021). AMAF, diagnosed as seropositive AM without a specific autoimmune disease, is not rare and is associated with less extensive LGE in the acute phase. In addition, AMAF patients had more favorable outcomes on 12-month CMR. Prospective studies are needed to address the clinical significance of this new concept and its long-term cardiovascular impact.
Keywords: Acute myocarditis; Antinuclear antibodies; Cardiac magnetic resonance; One-year follow-up.
© 2021. Springer Japan KK, part of Springer Nature.
References
-
- Caforio ALP, Marcolongo R, Basso C, Iliceto S (2015) Clinical presentation and diagnosis of myocarditis. Heart 101:1332–1344 - DOI
-
- Cooper LT (2009) Myocarditis. N Engl J Med 360:1526–1538 - DOI
-
- Caforio AL, Pankuweit S, Arbustini S, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron A, Elliott PM (2013) European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648 - DOI
-
- Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fitz P, Dippon J, Bock C-T, Kingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–2190 - DOI
-
- Eckart RE, Scoville SL, Campbell CL, Shru EA, Stajduhar KC, Potter RN, Pearse LA, Virmani R (2004) Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141:829–834 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
